Notably, p63 and TCF7—which typically co-express and co-localize—were much less frequently observed together in BRCA1 carriers, suggesting that these alterations in myoepithelial cells may contribute to their increased breast cancer risk. This evidence concerns the gene TCF7 and breast cancer.